Breadcrumb Navigation

DOPA PET (Neurology)

Dihydroxy-phenylalanine (DOPA) is an endogenous precursor of amino acids and messenger substances.

18F-DOPA traces the presynaptic function of the dopaminergic system. It can well differentiate between neurodegeneration and essential tremor.

Figure: FDOPA PET of a patient with Parkinson’s disease, the tracer uptake in the right putamen is reduced.
Figure: FDOPA PET of a patient with Parkinson’s disease, the tracer uptake in the right putamen is reduced.

Indications

Unfortunately, 18F-DOPA-PET is not reimbursed by the health insurance company. For this examination, it is necessary to obtain a confirmation of costs from the referring doctor in advance, or the costs incurred must partly be borne by the patient himself.

Details see PDF, page 105ff

In addition, for licensing reasons, the substance is only produced a few days per month in France and has to be imported. You can therefore expect a certain waiting time.

Responsible doctors

Martin Hüllner, PD Dr. med.

Senior Attending Physician, Department of Nuclear Medicine
Deputy Clinic Director, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine
Diagnostic Neuroradiologist, Department of Nuclear Medicine

Specialties: Oncological, neurological and musculoskeletal imaging
Tel. +41 44 255 25 80

Lars Husmann, Prof. Dr. med.

Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine

Specialties: PET/CT Imaging
Tel. +41 43 253 87 99

David Kenkel, Dr. med.

Attending Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine

Specialties: Oncological imaging (PET, SPECT, CT, MRI)

Cäcilia Mader, Dr. med.

Senior Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine
Neuroradiologist, Department of Nuclear Medicine

Specialties: Oncological, neurological and musculoskeletal hybrid imaging
Tel. +41 43 253 88 02

Alexander Maurer, Dr. med.

Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine

Specialties: Oncologic imaging, Hybrid imaging of prostate cancer
Tel. +41 43 253 88 09

Michael Messerli, PD Dr. med.

Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine

Specialties: Hybrid imaging of oncological diseases (PET, SPECT, CT, MRI)
Tel. +41 43 253 88 03

For patients

As a patient, you cannot register directly for a consultation. Please have your family doctor, specialist refer you. If you have any questions, please use our contact form.

Tel. +41 44 255 35 55

For referring physicians

Simply assign your patient via registration form.

Tel. +41 44 255 35 55

Medical information hotline: 08.00-18.00 o’clock: +41 44 255 15 02